RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
Cellophil™ Biomedical Polymers - New and superior biomedical polymers for drug delivery and new standards in the medical device industry
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
In Vivo Non-Invasive Diagnostic Method Using Magnetic Resonance Spectroscopy of Aspartate Transaminase
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Vessel Delineation in Magnetic Resonance Angiographic Images
Algorithms and computer-implemented methods for tracking the paths of vessels in magnetic resonance angiography More
Cripto-1 as a Biomarker for Cardiac Ischemia
Cripto-1 is overexpressed in infarcted myocardial tissue More
Active Guidewire Visualization Device and System for MRI Guided Interventions
The guidewire design, and its coupled system, enables interventionalists to visualize the location of the tip and distal shaft of an MRI compatible guidewire relative to the vascular system and surrounding anatomy. More
Novel Treatment of Vascular Cognitive Impairment
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Early Detection of Dysfunctional Vascular Endothelium (TID - 32)
Provides methods that allow for real time detection of endothelial dysfunction. More
METHODS FOR SCREENING A THERAPEUTIC AGENT OF HEART FAILURE, FIBROSIS AND INFLAMMATION AND COMPOSITIONS COMPRISING THE SAME
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Displaying 1..10 of 15 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Epidemiology: Acute Coronary Syndrome - Now affecting primarily the oldest populations
Jul 2011 - 46 pages - $3,800
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Innovations in Cardiovascular Disease Management
May 2007 - 183 pages - $2,875
The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Mar 2010 - 180 pages - $3,835
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
The Medicines Company: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 49 pages - $495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us